NCMD Research Seminar Series 5th June 2026
NCMD Research Seminar Series 5th June 2026
Presenter: Dr Paul Shotbolt, Clinical Reader in Neuropsychiatry and Neurotechnology, Director, Integrated Academic Trainee Lead (General Adult); Programme Leader, MSc in Clinical Neuropsychiatry, Institute of Psychiatry, Psychology and Neuroscience, KCL.
Presentation title: Neurotechnology in psychiatry
Neurological and psychiatric disorders affect hundreds of millions globally, and patients with these disorders only partially respond to any form of
treatment. Neurotechnology could transform how we understand, diagnose, and treat neuropsychiatric disorders. In this talk I will discuss current neurotechnology treatments available in the NHS. I will then present some of our studies at Maudsley Neurotechnology.
I studied medicine at Cambridge University and Guy’s and St. Thomas’s Hospitals, qualifying in 1996. I completed all my psychiatric training at the Maudsley Hospital, obtaining my certificate of completion of training in 2007. I took an academic route through my higher training, working as a research fellow in the Department of Cognitive Neuropsychiatry.
I was awarded a Wellcome Translational Training Fellowship in 2007, and between 2007-2010 I was the principal investigator on several neurochemical imaging studies at the PET centre at Imperial College, Hammersmith.
In 2010 I took up my current position of Consultant Neuropsychiatrist at the Maudsley Hospital. In 2016 I was appointed to the post of Clinical Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience and am Programme Leader for the Clinical Neuropsychiatry MSc. Clinically I am interested in the neuropsychiatric aspects of Parkinson’s disease and other movement disorders, including functional neurological disorders (FND). I was a member of the latest NICE Guideline Development Group for Parkinson’s disease. I am the lead for the King’s Health Partners (KHP) FND workstream, which aims to optimise care pathways, training and research for FND. I also have a longstanding medicolegal practice focused on
neuropsychiatric aspects of traumatic brain injury.
Academically I have a strong interest in development of neurotechnology applications in neuropsychiatric disorders. I am the principal investigator on a study examining impulse control disorders pre- and post-Deep Brain Stimulation (DBS) for PD. Our group is developing personalised biomarker closed-loop DBS applications for neuropsychiatric conditions. I am also developing clinical applications of non-invasive techniques such as transcranial magnetic stimulation (TMS) and transcranial temporal interference stimulation (tTIS).
I am founding director of the new Maudsley Neurotechnology (MNT) centre. MNT aims to deliver evidencebased neurotechnology treatments for psychiatric disorders.
via TEAMS (click here to )
Meeting ID: 322 142 039 734 840
Passcode: b8Wk9iX9